News from anaptysbio, inc

Apr 03, 2014, 08:00 ET
AnaptysBio Leader in SHM for Antibody Therapeutics www.anaptysbio.com.  (PRNewsFoto/AnaptysBio, Inc.)

AnaptysBio Announces Issuance Of United States Patent Covering Proprietary Antibody Humanization Technology

 AnaptysBio, Inc., a leader in the discovery and development of therapeutic antibodies, announced today that the U.S. Patent and Trademark...

Mar 13, 2014, 07:01 ET
AnaptysBio Leader in SHM for Antibody Therapeutics www.anaptysbio.com.  (PRNewsFoto/AnaptysBio, Inc.)

AnaptysBio And TESARO Announce Strategic Immuno-Oncology Antibody Collaboration

AnaptysBio, Inc., a leader in the discovery and development of therapeutic antibodies, today announced a strategic immuno-oncology collaboration...

Jan 10, 2014, 08:00 ET
AnaptysBio Leader in SHM for Antibody Therapeutics www.anaptysbio.com.  (PRNewsFoto/AnaptysBio, Inc.)

AnaptysBio Announces Development Of Novel anti-IL33 Therapeutic Antibody

 AnaptysBio, Inc., a privately-held therapeutic antibody company today announced the development of a first-in-class therapeutic antibody to...

Dec 17, 2013, 08:00 ET

AnaptysBio Announces Antibody Development Agreement With Momenta

 AnaptysBio, Inc., a privately-held therapeutic antibody company today announced the initiation of an antibody development program with...

Oct 17, 2013, 07:00 ET
AnaptysBio Leader in SHM for Antibody Therapeutics www.anaptysbio.com.  (PRNewsFoto/AnaptysBio, Inc.)

AnaptysBio Receives Allowance Of US Patent Covering Proprietary ABELmAb™ Libraries

AnaptysBio, Inc., a leader in the discovery and development of therapeutic antibodies, announced today that it has received a Notice of Allowance...

Sep 24, 2013, 07:02 ET
AnaptysBio Leader in SHM for Antibody Therapeutics www.anaptysbio.com.  (PRNewsFoto/AnaptysBio, Inc.)

AnaptysBio Named a 2013 "Fierce 15" Winner

 AnaptysBio, Inc., a leader in the discovery and development of therapeutic antibodies, today announced its selection by the editors of...

Aug 29, 2013, 08:00 ET
AnaptysBio Leader in SHM for Antibody Therapeutics www.anaptysbio.com.  (PRNewsFoto/AnaptysBio, Inc.)

AnaptysBio Expands Immunotherapy Portfolio With Anti-PD-1 Antibody Combinations

 AnaptysBio, Inc., a leader in the discovery and development of therapeutic antibodies, today announced the expansion of its proprietary...

May 16, 2013, 08:00 ET
AnaptysBio Leader in SHM for Antibody Therapeutics www.anaptysbio.com.  (PRNewsFoto/AnaptysBio, Inc.)

AnaptysBio Awarded U.S. Government Contract To Develop Anti-Ricin Antibodies

AnaptysBio, Inc., a privately-held therapeutic antibody company, today announced the receipt of a contract award from the U.S. government for the...

Dec 04, 2012, 08:00 ET
AnaptysBio Leader in SHM for Antibody Therapeutics www.anaptysbio.com.  (PRNewsFoto/AnaptysBio, Inc.)

AnaptysBio Develops Novel Antibody Scaffold With Extreme Thermostability

 AnaptysBio, Inc., a privately-held therapeutic antibody company, today announced the publication of a novel full-length antibody...

Oct 18, 2012, 08:00 ET
AnaptysBio Leader in SHM for Antibody Therapeutics www.anaptysbio.com.  (PRNewsFoto/AnaptysBio, Inc.)

AnaptysBio Expands Patent Portfolio with Issuance of U.S. Patent to In Vitro Somatic Hypermutation

AnaptysBio, Inc., a privately held therapeutic antibody company, today announced the issuance of Patent # 8,288,160 entitled "Activation...

Aug 08, 2012, 08:00 ET
AnaptysBio Leader in SHM for Antibody Therapeutics www.anaptysbio.com.  (PRNewsFoto/AnaptysBio, Inc.)

Anaptysbio Expands Leadership Team With Addition Of Dr. Andrew J. Mcknight

 AnaptysBio, Inc., a privately held therapeutic antibody company, today announced the addition of Andrew J. McKnight, Ph.D. as Senior...

May 01, 2012, 08:00 ET
AnaptysBio Leader in SHM for Antibody Therapeutics www.anaptysbio.com.  (PRNewsFoto/AnaptysBio, Inc.)

AnaptysBio Announces Antibody Discovery Partnership With Gilead Sciences

AnaptysBio, Inc., a privately-held therapeutic antibody company, today announced an antibody discovery partnership with Gilead Sciences, Inc. to...

Apr 09, 2012, 08:00 ET
AnaptysBio Leader in SHM for Antibody Therapeutics www.anaptysbio.com.  (PRNewsFoto/AnaptysBio, Inc.)

AnaptysBio Announces Strategic Antibody Discovery Partnership With Celgene Corporation

AnaptysBio, Inc., a privately-held therapeutic antibody company, today announced a strategic partnership with Celgene Corporation to develop novel...

Mar 15, 2012, 10:00 ET
AnaptysBio Leader in SHM for Antibody Therapeutics www.anaptysbio.com.  (PRNewsFoto/AnaptysBio, Inc.)

AnaptysBio Adds Dr. David L. Lacey and Dr. Michael Gallatin to Therapeutic Advisory Board

 AnaptysBio, Inc., a privately held therapeutic antibody company, today announced the addition of David L. Lacey, M.D. and Michael Gallatin,...

Jan 06, 2012, 10:00 ET
AnaptysBio Leader in SHM for Antibody Therapeutics www.anaptysbio.com.  (PRNewsFoto/AnaptysBio, Inc.)

AnaptysBio Announces New Strategic Antibody Discovery

 AnaptysBio, Inc., a privately-held therapeutic antibody company, today announced the initiation of new strategic alliances with two partners:...

Dec 05, 2011, 15:00 ET
AnaptysBio Leader in SHM for Antibody Therapeutics www.anaptysbio.com.  (PRNewsFoto/AnaptysBio, Inc.)

AnaptysBio Describes Technology for the Discovery and Optimization of Fully Human Antibodies in Original Research Publication

 AnaptysBio, Inc., a privately-held therapeutic antibody company, today announced the publication of original research describing the...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge